Opportunities Preloader

Please Wait.....

Report

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) - Global Forecast to 2027

Market Report I 2022-06-02 I 225 Pages I MarketsandMarkets

The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%. The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products.

"The biomaterial as segment is anticipated to grow at the fastest growth rate during the forecast period."
Based on product type, the nerve repair and regenerations market is segmented into neurostimulation and neuromodulation devices and biomaterials. The biomaterials segment is expected to register the highest CAGR which is driven by the research investments, and R&D expenditure by the government and market players.

"The internal neurostimulation and neuromodulation segment is accounted for the largest share during the analysis period."
Based on the neurostimulation and neuromodulation application, the nerve repair & regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation neuromodulation segment is held the largest share during the forecast period owing to the rising cases of nerve related injuries and the high incidence of neurological disorders.

"Asia Pacific is estimated to register the highest CAGR during the study period. North America is expected to dominate the market share"
In this report, the nerve repair & regeneration market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Middle East & Africa and Latin America). In 2021, North America held the largest share of the market owing to the presence of the leading players and advanced healthcare infrastructure.
The market in Asia Pacific is projected to grow at the highest growth rate during the forecast period owing to the massive population base, increasing economical growth, improving healthcare infrastructure and healthcare expenditure, high reverence of the neurologic diseases and the rising demand

Breakdown of primary supply-side interviews, by company type, designation, and region:
- By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
- By Designation: C-level (30%), Director-level (34%), and Others (36%)
- By Region: North America (50%), Europe (32%), AsiaPacific (10%), and Rest of the World (8%)

List of players profiled in this report:
- Medtronic, plc. (Ireland)
- Boston Scientific Corporation (US),
- Abbott Laboratories (US)
- Axogen Corporation (US)
- Baxter (US)
- LivaNova PLC (UK)
- Integra LifeSciences (US)
- Neuronetics Inc. (US)
- Nevro Corp (US)
- NeuroPace Inc. (US)
- Polyganics (Netherlands)
- Soterix Medical Inc (US)
- Synapse Biomedical Inc. (US)
- Aleva Neurotherapeutics SA (Switzerland)
- Collagen Matrix Inc. (US)
- KeriMedical (Switzerland)
- BioWaveGO USA (US)
- NeuroSigma Inc. (US)
- tVNS Technologies GmbH (Germany)
- GiMer Medical (Taiwan)
- Checkpoint Surgical Inc. (US)
- Renishaw PLC (UK)
- Alafair Biosciences, Inc. (US)
- electroCore, Inc. (US)

Research Coverage
This report studies the nerve repair & regeneration market based on product, application and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total nerve repair & regeneration market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the nerve repair and regeneration offered by the top 16 players in the market. The report analyzes the nerve repair & regeneration market by product and region
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various nerve repair and regeneration across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nerve repair & regeneration market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the nerve repair & regeneration market

1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 37
TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY 37
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
FIGURE 1 NERVE REPAIR & REGENERATION MARKET SEGMENTATION 38
1.3.2 YEARS CONSIDERED FOR THE STUDY 38
1.4 CURRENCY 39
TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 39
1.5 STAKEHOLDERS 39
1.6 SUMMARY OF CHANGES MADE 39
1.7 LIMITATIONS 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 2 RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
2.1.2.1 Key data from primary sources 43
TABLE 3 KEY DATA FROM PRIMARY SOURCES 44
2.1.2.2 Key industry insights 45
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
2.2 MARKET SIZE ESTIMATION 46
FIGURE 4 NERVE REPAIR & REGENERATION MARKET - REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 47
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF NERVE REPAIR & REGENERATION PRODUCTS 48
FIGURE 6 CAGR PROJECTIONS 49
FIGURE 7 TOP-DOWN APPROACH 50
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 8 DATA TRIANGULATION 51
2.4 MARKET SHARE ANALYSIS 52
2.5 ASSUMPTIONS FOR THE STUDY 52
2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY 52
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS 53
2.7 RISK ASSESSMENT 53
TABLE 4 RISK ASSESSMENT 53
3 EXECUTIVE SUMMARY 54
FIGURE 9 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2022 VS. 2027 (USD BILLION) 54
4 PREMIUM INSIGHTS 59
4.1 NERVE REPAIR & REGENERATION MARKET OVERVIEW 59
4.2 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT & COUNTRY (2021) 59
4.3 NERVE REPAIR & REGENERATION MARKET, BY REGION (2022 VS. 2027) 60
FIGURE 19 NORTH AMERICA TO DOMINATE THE NERVE REPAIR & REGENERATION MARKET DURING THE FORECAST PERIOD 60
4.4 NERVE REPAIR & REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 21 NERVE REPAIR & REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 61
5.2.1.1 High incidence of nerve injuries 61
5.2.1.2 Rising focus on neuromodulation & neurostimulation technologies 62
5.2.1.3 Rising geriatric population and the subsequent increase in the prevalence of neurological disorders 62
5.2.1.4 Rising government support for research on neurological disorders 63
FIGURE 22 FUNDING FOR RESEARCH BY THE NIH (US) 63
5.2.2 OPPORTUNITIES 64
5.2.2.1 Emerging markets 64
FIGURE 23 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA, 2012-2019 64
5.2.2.2 Advances in stem cell therapy in nerve repair & regeneration 64
5.2.2.3 Growing research projects in neurology 65
FIGURE 24 RESEARCH PAPERS PUBLISHED (2011-2021) 65
TABLE 5 INDICATIVE LIST: NEUROMODULATION CLINICAL TRAILS 65
5.2.3 CHALLENGES 66
5.2.3.1 Donor-site morbidity 66
5.2.3.2 Difficulties in treating large nerve gaps 66
5.2.3.3 Stringent regulatory frameworks and time-consuming approval processes 66
5.2.3.4 Greater preference for drug therapies over nerve repair & regeneration products 66
5.2.3.5 Shortage of trained professionals 66
5.2.3.6 Product recalls 67
TABLE 6 MAJOR PRODUCT RECALLS 67
5.3 IMPACT OF COVID-19 ON THE NERVE REPAIR & REGENERATION MARKET 67
FIGURE 25 REVENUE OF NEUROMODULATION SEGMENT BY THE TOP THREE PLAYERS, 2019-2021 (USD MILLION) 68
5.4 PRICING ANALYSIS 69
TABLE 7 AVERAGE SELLING PRICES OF NERVE WRAP AND NERVE CONDUIT 69
TABLE 8 AVERAGE SELLING PRICES OF NERVE WRAP OF KEY COMPANIES 69
TABLE 9 AVERAGE SELLING PRICES OF NERVE CONDUITS OF KEY COMPANIES 69
6 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT 70
6.1 INTRODUCTION 71
TABLE 10 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2018-2020 (USD MILLION) 71
TABLE 11 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2021-2027 (USD MILLION) 71
6.2 NEUROSTIMULATION AND NEUROMODULATION DEVICES 71
TABLE 12 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 72
TABLE 13 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 72
TABLE 14 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 72
TABLE 15 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 72
6.2.1 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES 73
TABLE 16 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 73
TABLE 17 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 73
TABLE 18 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 74
TABLE 19 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 74
6.2.1.1 Spinal cord stimulation devices 74
6.2.1.1.1 Increasing incidence of spinal cord injuries to support the growth of this segment 74
TABLE 20 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION,
2018-2020 (USD MILLION) 75
TABLE 21 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION,
2021-2027 (USD MILLION) 75
6.2.1.2 Deep brain stimulation devices 76
6.2.1.2.1 Rising incidence of neurodegenerative diseases among the senior population drives the growth of this segment 76
TABLE 22 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION,
2018-2020 (USD MILLION) 76
TABLE 23 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION,
2021-2027 (USD MILLION) 77
6.2.1.3 Vagus nerve stimulation devices 77
6.2.1.3.1 Increasing incidence of epilepsy to support the market growth for VNS devices 77
TABLE 24 VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION,
2018-2020 (USD MILLION) 77
TABLE 25 VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION,
2021-2027 (USD MILLION) 78
6.2.1.4 Sacral nerve stimulation devices 78
6.2.1.4.1 Increasing incidence of urological disorders to drive the growth of this segment 78
TABLE 26 SACRAL NERVE STIMULATION DEVICES OFFERED BY SOME MARKET PLAYERS 78
TABLE 27 SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION,
2018-2020 (USD MILLION) 79
TABLE 28 SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION,
2021-2027 (USD MILLION) 79
6.2.1.5 Gastric electrical stimulation devices 79
6.2.1.5.1 GES is mainly used for the treatment of GERD and gastroparesis 79
TABLE 29 GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION,
2018-2020 (USD MILLION) 80
TABLE 30 GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION,
2021-2027 (USD MILLION) 80
6.2.2 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES 80
TABLE 31 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 80
TABLE 32 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 81
TABLE 33 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION BY REGION, 2018-2020 (USD MILLION) 81
TABLE 34 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 81
6.2.2.1 Transcutaneous electrical nerve stimulation devices 82
6.2.2.1.1 Extensive use in healthcare and low costs to support the growth of this segment 82
TABLE 35 TENS DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 82
TABLE 36 TENS DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 83
6.2.2.2 Transcranial Magnetic Stimulation Devices 83
6.2.2.2.1 Minimal patient discomfort associated with TMS to support the adoption of TMS devices 83
TABLE 37 TMS DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 83
TABLE 38 TMS DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 84
6.2.2.3 Respiratory Electric Stimulation Devices 84
6.2.2.3.1 Increasing incidence of spinal cord injuries to support the growth of this segment 84
TABLE 39 RES DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 84
TABLE 40 RES DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 85
6.3 BIOMATERIALS 85
TABLE 41 BIOMATERIALS MARKET, BY PRODUCT TYPE, 2018-2020 (USD MILLION) 85
TABLE 42 BIOMATERIALS MARKET, BY PRODUCT TYPE, 2021-2027 (USD MILLION) 85
TABLE 43 BIOMATERIALS MARKET, BY REGION, 2018-2020 (USD MILLION) 86
TABLE 44 BIOMATERIALS MARKET, BY REGION, 2021-2027 (USD MILLION) 86
6.3.1 NERVE CONDUITS 86
6.3.1.1 Increasing research in the field of nerve repair to support segment growth 86
TABLE 45 NERVE CONDUITS OFFERED BY SOME MARKET PLAYERS 87
TABLE 46 NERVE CONDUITS MARKET, BY REGION, 2018-2020 (USD MILLION) 87
TABLE 47 NERVE CONDUITS MARKET, BY REGION, 2021-2027 (USD MILLION) 87
6.3.2 NERVE WRAPS 88
6.3.2.1 Increasing incidence of peripheral injuries to drive the growth of this segment 88
TABLE 48 NERVE WRAPS OFFERED BY SOME MARKET PLAYERS 88
TABLE 49 NERVE WRAPS MARKET, BY REGION, 2018-2020 (USD MILLION) 88
TABLE 50 NERVE WRAPS MARKET, BY REGION, 2021-2027 (USD MILLION) 88
7 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION 89
7.1 INTRODUCTION 90
7.2 NEUROSTIMULATION & NEUROMODULATION 90
TABLE 51 NEUROSTIMULATION & NEUROMODULATION MARKET, BY TYPE,
2018-2020 (USD MILLION) 90
TABLE 52 NEUROSTIMULATION & NEUROMODULATION MARKET, BY TYPE,
2021-2027 (USD MILLION) 90
TABLE 53 NEUROSTIMULATION & NEUROMODULATION APPLICATIONS, BY REGION, 2018-2020 (USD MILLION) 91
TABLE 54 NEUROSTIMULATION & NEUROMODULATION APPLICATIONS, BY REGION, 2021-2027 (USD MILLION) 91
7.2.1 INTERNAL NEUROSTIMULATION & NEUROMODULATION 91
7.2.1.1 Minimally invasive nature and reversibility to support the growth of this segment 91
TABLE 55 INTERNAL NEUROSTIMULATION & NEUROMODULATION MARKET, BY REGION, 2018-2020 (USD MILLION) 91
TABLE 56 INTERNAL NEUROSTIMULATION & NEUROMODULATION MARKET, BY REGION, 2021-2027 (USD MILLION) 92
7.2.2 EXTERNAL NEUROSTIMULATION & NEUROMODULATION 92
7.2.2.1 Rising cases of noninvasive procedures to ensure the growth of this segment 92
TABLE 57 EXTERNAL NEUROSTIMULATION & NEUROMODULATION MARKET, BY REGION, 2018-2020 (USD MILLION) 92
TABLE 58 EXTERNAL NEUROSTIMULATION & NEUROMODULATION MARKET, BY REGION, 2021-2027 (USD MILLION) 92
7.3 NERVE REPAIR & REGENERATION BIOMATERIALS 93
TABLE 59 NERVE REPAIR & REGENERATION BIOMATERIALS MARKET, BY TYPE,
2018-2020 (USD MILLION) 93
TABLE 60 NERVE REPAIR & REGENERATION BIOMATERIALS MARKET, BY TYPE,
2021-2027 (USD MILLION) 93
7.3.1 DIRECT NERVE REPAIR/NEURORRHAPHY 93
TABLE 61 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY TYPE,
2018-2020 (USD MILLION) 93
TABLE 62 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY TYPE,
2021-2027 (USD MILLION) 94
TABLE 63 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY REGION,
2018-2020 (USD MILLION) 94
TABLE 64 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY REGION,
2021-2027 (USD MILLION) 94
7.3.1.1 Epineural repair 94
7.3.1.1.1 Short operating times, ease, and minimal suturing requirements to drive the growth of this segment 94
TABLE 65 EPINEURAL REPAIR MARKET, BY REGION, 2018-2020 (USD MILLION) 95
TABLE 66 EPINEURAL REPAIR MARKET, BY REGION, 2021-2027 (USD MILLION) 95
7.3.1.2 Perineural repair 95
7.3.1.2.1 Perineural repair is a highly complex surgery, which has affected its prospects in this market 95
TABLE 67 PERINEURAL REPAIR MARKET, BY REGION, 2018-2020 (USD MILLION) 95
TABLE 68 PERINEURAL REPAIR MARKET, BY REGION, 2021-2027 (USD MILLION) 96
7.3.1.3 Group fascicular repair 96
7.3.1.3.1 Long procedural time to restrain the growth of this market 96
TABLE 69 GROUP FASCICULAR REPAIR MARKET, BY REGION,
2018-2020 (USD MILLION) 96
TABLE 70 GROUP FASCICULAR REPAIR MARKET, BY REGION,
2021-2027 (USD MILLION) 96
7.3.2 NERVE GRAFTING 97
TABLE 71 NERVE GRAFTING MARKET, BY TYPE, 2018-2020 (USD MILLION) 97
TABLE 72 NERVE GRAFTING MARKET, BY TYPE, 2021-2027 (USD MILLION) 97
TABLE 73 NERVE GRAFTING MARKET, BY REGION, 2018-2020 (USD MILLION) 97
TABLE 74 NERVE GRAFTING MARKET, BY REGION, 2021-2027 (USD MILLION) 98
7.3.2.1 Autografts 98
7.3.2.1.1 Autografts are considered the gold standard for nerve gap treatment 98
TABLE 75 AUTOGRAFTS MARKET, BY REGION, 2018-2020 (USD MILLION) 98
TABLE 76 AUTOGRAFTS MARKET, BY REGION, 2021-2027 (USD MILLION) 99
7.3.2.2 Allografts 99
7.3.2.2.1 Benefits of allografts over autograft usage to drive the growth of this segment 99
TABLE 77 ALLOGRAFTS MARKET, BY REGION, 2018-2020 (USD MILLION) 99
TABLE 78 ALLOGRAFTS MARKET, BY REGION, 2021-2027 (USD MILLION) 99
7.3.2.3 Xenografts 100
7.3.2.3.1 Need for immunosuppression associated with xenograft use to restrain the growth of this segment 100
TABLE 79 XENOGRAFTS MARKET, BY REGION, 2018-2020 (USD MILLION) 100
TABLE 80 XENOGRAFTS MARKET, BY REGION, 2021-2027 (USD MILLION) 100
7.3.3 STEM CELL THERAPY 100
7.3.3.1 The high future growth prospects counterbalance the low penetration of stem cell therapy 100
TABLE 81 STEM CELL THERAPY MARKET, BY REGION, 2018-2020 (USD MILLION) 101
TABLE 82 STEM CELL THERAPY MARKET, BY REGION, 2021-2027 (USD MILLION) 101
8 NERVE REPAIR & REGENERATION MARKET, BY REGION 102
8.1 INTRODUCTION 103
TABLE 83 NERVE REPAIR & REGENERATION MARKET, BY REGION,
2018-2020 (USD MILLION) 103
TABLE 84 NERVE REPAIR & REGENERATION MARKET, BY REGION,
2021-2027 (USD MILLION) 103
8.2 NORTH AMERICA 104
TABLE 85 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY REGION, 2018-2020 (USD MILLION) 105
TABLE 86 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY REGION, 2021-2027 (USD MILLION) 106
TABLE 87 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2018-2020 (USD MILLION) 106
TABLE 88 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2021-2027 (USD MILLION) 106
TABLE 89 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 106
TABLE 90 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 107
TABLE 91 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 107
TABLE 92 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 107
TABLE 93 NORTH AMERICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 107
TABLE 94 NORTH AMERICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 108
TABLE 95 NORTH AMERICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 108
TABLE 96 NORTH AMERICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 108
TABLE 97 NORTH AMERICA: BIOMATERIALS MARKET, BY REGION,
2018-2020 (USD MILLION) 109
TABLE 98 NORTH AMERICA: BIOMATERIALS MARKET, BY REGION,
2021-2027 (USD MILLION) 109
TABLE 99 NORTH AMERICA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 109
TABLE 100 NORTH AMERICA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 109
TABLE 101 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2020 (USD MILLION) 110
TABLE 102 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 110
TABLE 103 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY,
2018-2020 (USD MILLION) 110
TABLE 104 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY,
2021-2027 (USD MILLION) 110
TABLE 105 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE,
2018-2020 (USD MILLION) 111
TABLE 106 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE,
2021-2027 (USD MILLION) 111
8.2.1 US 111
8.2.1.1 The high prevalence of neurological disorders drives the demand for nerve repair & regeneration products in the US 111
TABLE 107 COMPANY PRODUCTS THAT RECEIVED FDA APPROVAL IN THE US 112
TABLE 108 US: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 112
TABLE 109 US: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 113
TABLE 110 US: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 113
TABLE 111 US: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 113
TABLE 112 US: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 114
TABLE 113 US: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 114
TABLE 114 US: BIOMATERIALS MARKET, BY PRODUCT TYPE, 2018-2020 (USD MILLION) 114
TABLE 115 US: BIOMATERIALS MARKET, BY PRODUCT TYPE, 2021-2027 (USD MILLION) 114
8.2.2 CANADA 115
8.2.2.1 Rising health expenditure and increasing disease prevalence will drive market growth 115
TABLE 116 NEUROLOGICAL CONDITIONS IN CANADA 115
TABLE 117 CANADA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 116
TABLE 118 CANADA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 116
TABLE 119 CANADA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 117
TABLE 120 CANADA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 117
TABLE 121 CANADA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 117
TABLE 122 CANADA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 118
TABLE 123 CANADA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 118
TABLE 124 CANADA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 118
8.3 EUROPE 118
TABLE 125 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY REGION,
2018-2020 (USD MILLION) 119
TABLE 126 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY REGION,
2021-2027 (USD MILLION) 120
TABLE 127 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2018-2020 (USD MILLION) 120
TABLE 128 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2021-2027 (USD MILLION) 120
TABLE 129 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 121
TABLE 130 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 121
TABLE 131 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 121
TABLE 132 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 122
TABLE 133 EUROPE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 122
TABLE 134 EUROPE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 122
TABLE 135 EUROPE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 123
TABLE 136 EUROPE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 123
TABLE 137 EUROPE: BIOMATERIALS MARKET, BY REGION, 2018-2020 (USD MILLION) 123
TABLE 138 EUROPE: BIOMATERIALS MARKET, BY REGION, 2021-2027 (USD MILLION) 124
TABLE 139 EUROPE: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 124
TABLE 140 EUROPE: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 124
TABLE 141 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2020 (USD MILLION) 124
TABLE 142 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 125
TABLE 143 EUROPE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 125
TABLE 144 EUROPE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 125
TABLE 145 EUROPE: BIOMATERIALS MARKET, BY APPLICATION,
2018-2020 (USD MILLION) 126
TABLE 146 EUROPE: BIOMATERIALS MARKET, BY APPLICATION,
2021-2027 (USD MILLION) 126
8.3.1 GERMANY 126
8.3.1.1 Rising healthcare expenditure and favorable reimbursement policies to ensure strong market growth 126
TABLE 147 GERMANY: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 127
TABLE 148 GERMANY: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 127
TABLE 149 GERMANY: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 127
TABLE 150 GERMANY: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 128
TABLE 151 GERMANY: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 128
TABLE 152 GERMANY: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 128
TABLE 153 GERMANY: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 129
TABLE 154 GERMANY: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 129
8.3.2 UK 129
8.3.2.1 Government initiatives to drive the growth of the nerve repair & regeneration market in the UK 129
TABLE 155 PRODUCTS RECEIVED CE APPROVAL 130
TABLE 156 UK: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 130
TABLE 157 UK: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 130
TABLE 158 UK: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 131
TABLE 159 UK: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 131
TABLE 160 UK: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 131
TABLE 161 UK: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 132
TABLE 162 UK: BIOMATERIALS MARKET, BY PRODUCT TYPE, 2018-2020 (USD MILLION) 132
TABLE 163 UK: BIOMATERIALS MARKET, BY PRODUCT TYPE, 2021-2027 (USD MILLION) 132
8.3.3 FRANCE 132
8.3.3.1 Favorable healthcare reforms to support the market growth in France 132
TABLE 164 FRANCE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 133
TABLE 165 FRANCE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 133
TABLE 166 FRANCE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 133
TABLE 167 FRANCE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 134
TABLE 168 FRANCE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 134
TABLE 169 FRANCE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 134
TABLE 170 FRANCE: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 135
TABLE 171 FRANCE: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 135
8.3.4 ITALY 135
8.3.4.1 Easy access to healthcare services has supported the demand for nerve repair & regeneration products in Italy 135
TABLE 172 ITALY: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 136
TABLE 173 ITALY: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 136
TABLE 174 ITALY: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 136
TABLE 175 ITALY: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 137
TABLE 176 ITALY: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 137
TABLE 177 ITALY: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 137
TABLE 178 ITALY: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 138
TABLE 179 ITALY: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 138
8.3.5 SPAIN 138
8.3.5.1 The growing geriatric population and the subsequent increase in the incidence of neurological disorders drive the market growth 138
TABLE 180 SPAIN: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 139
TABLE 181 SPAIN: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 139
TABLE 182 SPAIN: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 139
TABLE 183 SPAIN: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 140
TABLE 184 SPAIN: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 140
TABLE 185 SPAIN: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 140
TABLE 186 SPAIN: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 141
TABLE 187 SPAIN: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 141
8.3.6 REST OF EUROPE 141
TABLE 188 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, 2017 VS. 2050 142
TABLE 189 ROE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 142
TABLE 190 ROE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 142
TABLE 191 ROE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 143
TABLE 192 ROE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 143
TABLE 193 ROE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 143
TABLE 194 ROE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 144
TABLE 195 ROE: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 144
TABLE 196 ROE: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 144
8.4 ASIA PACIFIC 144
TABLE 197 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY REGION, 2018-2020 (USD MILLION) 145
TABLE 198 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY REGION, 2021-2027 (USD MILLION) 146
TABLE 199 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2018-2020 (USD MILLION) 146
TABLE 200 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2021-2027 (USD MILLION) 146
TABLE 201 ASIA PACIFIC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 146
TABLE 202 ASIA PACIFIC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 147
TABLE 203 ASIA PACIFIC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 147
TABLE 204 ASIA PACIFIC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 147
TABLE 205 ASIA PACIFIC: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 148
TABLE 206 ASIA PACIFIC: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 148
TABLE 207 ASIA PACIFIC: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 148
TABLE 208 ASIA PACIFIC: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 149
TABLE 209 ASIA PACIFIC: BIOMATERIALS MARKET, BY REGION,
2018-2020 (USD MILLION) 149
TABLE 210 ASIA PACIFIC: BIOMATERIALS MARKET, BY REGION,
2021-2027 (USD MILLION) 149
TABLE 211 ASIA PACIFIC: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 149
TABLE 212 ASIA PACIFIC: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 150
TABLE 213 ASIA PACIFIC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2020 (USD MILLION) 150
TABLE 214 ASIA PACIFIC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 150
TABLE 215 ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION,
2018-2020 (USD MILLION) 150
TABLE 216 ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION,
2021-2027 (USD MILLION) 151
8.4.1 JAPAN 151
8.4.1.1 Japan dominates the Asia Pacific market for nerve repair & regeneration due to its high geriatric population 151
TABLE 217 JAPAN: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 152
TABLE 218 JAPAN: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 152
TABLE 219 JAPAN: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 152
TABLE 220 JAPAN: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 153
TABLE 221 JAPAN: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 153
TABLE 222 JAPAN: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 153
TABLE 223 JAPAN: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 154
TABLE 224 JAPAN: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 154
8.4.2 CHINA 154
8.4.2.1 Rising healthcare expenditure and growing disease prevalence to ensure strong market growth 154
FIGURE 28 CHINA: CURRENT HEALTH EXPENDITURE PER CAPITA (CURRENT USD) 155
TABLE 225 CHINA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 155
TABLE 226 CHINA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 155
TABLE 227 CHINA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 156
TABLE 228 CHINA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 156
TABLE 229 CHINA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 156
TABLE 230 CHINA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 157
TABLE 231 CHINA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 157
TABLE 232 CHINA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 157
8.4.3 INDIA 157
8.4.3.1 Changing government policies to have a positive impact on the market growth for nerve repair & regeneration 157
TABLE 233 INDIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 158
TABLE 234 INDIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 158
TABLE 235 INDIA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 159
TABLE 236 INDIA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 159
TABLE 237 INDIA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 159
TABLE 238 INDIA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 160
TABLE 239 INDIA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 160
TABLE 240 INDIA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 160
8.4.4 REST OF ASIA PACIFIC (ROAPAC) 160
TABLE 241 ROAPAC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 161
TABLE 242 ROAPAC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 161
TABLE 243 ROAPAC: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 162
TABLE 244 ROAPAC: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 162
TABLE 245 ROAPAC: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 162
TABLE 246 ROAPAC: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 163
TABLE 247 ROAPAC: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 163
TABLE 248 ROAPAC: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 163

8.5 REST OF THE WORLD (ROW) 163
TABLE 249 ROW: NERVE REPAIR & REGENERATION MARKET, BY REGION,
2018-2020 (USD MILLION) 164
TABLE 250 ROW: NERVE REPAIR & REGENERATION MARKET, BY REGION,
2021-2027 (USD MILLION) 164
TABLE 251 ROW: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2018-2020 (USD MILLION) 164
TABLE 252 ROW: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT,
2021-2027 (USD MILLION) 164
TABLE 253 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION) 165
TABLE 254 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2021-2027 (USD MILLION) 165
TABLE 255 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 165
TABLE 256 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 165
TABLE 257 ROW: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 166
TABLE 258 ROW: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 166
TABLE 259 ROW: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 166
TABLE 260 ROW: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 167
TABLE 261 ROW: BIOMATERIALS MARKET, BY REGION, 2018-2020 (USD MILLION) 167
TABLE 262 ROW: BIOMATERIALS MARKET, BY REGION, 2021-2027 (USD MILLION) 167
TABLE 263 ROW: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 167
TABLE 264 ROW: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 168
TABLE 265 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2020 (USD MILLION) 168
TABLE 266 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 168
TABLE 267 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2018-2020 (USD MILLION) 168
TABLE 268 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 169
8.5.1 LATIN AMERICA 169
8.5.1.1 High incidence rate of Parkinson's disease to support the market growth 169
FIGURE 29 POPULATION AGED 65 YEARS AND ABOVE (AS A PERCENTAGE OF THE TOTAL POPULATION), 2013-2018 169
TABLE 269 LATIN AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 170
TABLE 270 LATIN AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 170
TABLE 271 LATIN AMERICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 170
TABLE 272 LATIN AMERICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 171
TABLE 273 LATIN AMERICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 171
TABLE 274 LATIN AMERICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 171
TABLE 275 LATIN AMERICA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 172
TABLE 276 LATIN AMERICA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 172
8.5.2 MIDDLE EAST & AFRICA 172
8.5.2.1 Lack of health awareness and poor reimbursement policies to restrict the market growth 172
TABLE 277 MIDDLE EAST & AFRICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2020 (USD MILLION) 173
TABLE 278 MIDDLE EAST & AFRICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2021-2027 (USD MILLION) 173
TABLE 279 MIDDLE EAST & AFRICA:INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE,
2018-2020 (USD MILLION) 173
TABLE 280 MIDDLE EAST & AFRICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE,
2021-2027 (USD MILLION) 174
TABLE 281 MIDDLE EAST & AFRICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE,
2018-2020 (USD MILLION) 174
TABLE 282 MIDDLE EAST & AFRICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE,
2021-2027 (USD MILLION) 174
TABLE 283 MIDDLE EAST & AFRICA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2018-2020 (USD MILLION) 175
TABLE 284 MIDDLE EAST & AFRICA: BIOMATERIALS MARKET, BY PRODUCT TYPE,
2021-2027 (USD MILLION) 175
9 COMPETITIVE LANDSCAPE 176
9.1 OVERVIEW 176
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 176
TABLE 285 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE NERVE REPAIR & REGENERATION MARKET (2018 TO 2022) 176
9.3 MARKET SHARE ANALYSIS, 2021 177
FIGURE 30 GLOBAL NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2021 177
TABLE 286 NERVE REPAIR & REGENERATION MARKET: DEGREE OF COMPETITION 177
9.4 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 178
9.4.1 STARS 178
9.4.2 PERVASIVE PLAYERS 178
9.4.3 EMERGING LEADERS 179
9.4.4 PARTICIPANTS 179
FIGURE 31 NERVE REPAIR & REGENERATION MARKET (GLOBAL): COMPANY EVALUATION QUADRANT, 2021 179
9.5 COMPANY EVALUATION QUADRANT (SMES/STARTUPS) 180
9.5.1 PROGRESSIVE COMPANIES 180
9.5.2 RESPONSIVE COMPANIES 180
9.5.3 STARTING BLOCKS 180
9.5.4 DYNAMIC COMPANIES 180
FIGURE 32 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 181
9.6 COMPETITIVE BENCHMARKING 181
9.6.1 COMPANY PRODUCT FOOTPRINT (27 COMPANIES) 182
9.6.2 COMPANY REGIONAL FOOTPRINT 183
9.6.3 COMPANY FOOTPRINT 184
9.7 COMPETITIVE SITUATION AND TRENDS 185
9.7.1 PRODUCT LAUNCHES AND APPROVALS 185
TABLE 287 PRODUCT LAUNCHES AND APPROVALS, 2018-2022 185
9.7.2 DEALS 186
TABLE 288 DEALS, 2018-2022 186
9.7.3 OTHER DEVELOPMENTS 187
TABLE 289 OTHER DEVELOPMENTS, 2018-2022 187
10 COMPANY PROFILES 188
10.1 KEY PLAYERS 188
(Business overview, Products offered, Recent developments, MNM Views, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats)*
10.1.1 MEDTRONIC, PLC. 188
TABLE 290 MEDTRONIC PLC: BUSINESS OVERVIEW 188
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 189
10.1.2 BOSTON SCIENTIFIC CORPORATION 192
TABLE 291 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 192
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 193
10.1.3 ABBOTT LABORATORIES 196
TABLE 292 ABBOTT LABORATORIES: BUSINESS OVERVIEW 196
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 197
10.1.4 AXOGEN CORPORATION. 199
TABLE 293 AXOGEN CORPORATION.: BUSINESS OVERVIEW 199
FIGURE 36 AXOGEN CORPORATION.: COMPANY SNAPSHOT (2021) 200
10.1.5 BAXTER 201
TABLE 294 BAXTER: BUSINESS OVERVIEW 201
FIGURE 37 BAXTER: COMPANY SNAPSHOT (2021) 202
10.1.6 LIVANOVA PLC 204
TABLE 295 LIVANOVA PLC: BUSINESS OVERVIEW 204
FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2021) 205
10.1.7 INTEGRA LIFESCIENCES 207
TABLE 296 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 207
FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2021) 208
10.1.8 NEURONETICS INC. 210
TABLE 297 NEURONETICS INC.: BUSINESS OVERVIEW 210
FIGURE 40 NEURONETICS INC.: COMPANY SNAPSHOT (2021) 211
10.1.9 NEVRO CORP. 213
TABLE 298 NEVRO CORP.: BUSINESS OVERVIEW 213
FIGURE 41 NEVRO CORP.: COMPANY SNAPSHOT (2021) 213
10.1.10 NEUROPACE INC. 215
TABLE 299 NEUROPACE INC.: BUSINESS OVERVIEW 215
FIGURE 42 NEUROPACE INC.: COMPANY SNAPSHOT (2021) 215
10.1.11 POLYGANICS 217
TABLE 300 POLYGANICS: BUSINESS OVERVIEW 217
10.1.12 SOTERIX MEDICAL INC. 218
TABLE 301 SOTERIX MEDICAL INC.: BUSINESS OVERVIEW 218
10.1.13 SYNAPSE BIOMEDICAL INC 220
TABLE 302 SYNAPSE BIOMEDICAL INC: BUSINESS OVERVIEW 220
10.1.14 ALEVA NEUROTHERAPEUTICS SA 221
TABLE 303 ALEVA NEUROTHERAPEUTICS: BUSINESS OVERVIEW 221
10.1.15 COLLAGEN MATRIX INC 222
TABLE 304 COLLAGEN MATRIX INC: BUSINESS OVERVIEW 222
10.1.16 KERIMEDICAL 223
TABLE 305 KERIMEDICAL: BUSINESS OVERVIEW 223
10.2 OTHER PLAYERS 224
10.2.1 BIOWAVEGO USA 224
TABLE 306 BIOWAVEGO USA: COMPANY OVERVIEW 224
10.2.2 NEUROSIGMA, INC. 224
TABLE 307 NEUROSIGMA, INC.: COMPANY OVERVIEW 224
10.2.3 TVNS TECHNOLOGIES GMBH 225
TABLE 308 TVNS TECHNOLOGIES GMBH: COMPANY OVERVIEW 225
10.2.4 GIMER MEDICAL 225
TABLE 309 GIMER MEDICAL: COMPANY OVERVIEW 225
10.2.5 CHECKPOINT SURGICAL INC. 226
TABLE 310 CHECKPOINT SURGICAL INC.: COMPANY OVERVIEW 226
10.2.6 RENISHAW PLC. 226
TABLE 311 RENISHAW PLC.: COMPANY OVERVIEW 226
10.2.7 ALAFAIR BIOSCIENCES, INC. 227
TABLE 312 ALAFAIR BIOSCIENCES, INC.: COMPANY OVERVIEW 227
10.2.8 ELECTROCORE, INC. 227
TABLE 313 ELECTROCORE, INC.: COMPANY OVERVIEW 227
*Details on Business overview, Products offered, Recent developments, MNM Views, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
11 APPENDIX 228
11.1 INDUSTRY INSIGHTS 228
11.2 DISCUSSION GUIDE 229
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 233
11.4 AVAILABLE CUSTOMIZATIONS 235
11.5 RELATED REPORTS 235
11.6 AUTHOR DETAILS 236

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW